Skip to content
Febris PharmaceuticalsUnusual Incidents Unit
GOI format
interrogationLevel 2 · RestrictedREC-1469122939

Anedonia®

Author
FLUFFERNUTTER
Filed
9 Aug 2026
Rating
+12
Length
1,316 words

Mister Sandman, bring me a dream? (1100 words)

THE SOHO TATTLETALE

Your Weekly Source of Secondhand News

BackDoor SoHoAUGUST 8TH$2 - NO REFUNDS

SOHO "LIEDOWN" FEVER CONTINUES

LAW ENFORCEMENT ACTION LACKING AGAINST SPREAD OF UNKNOWN OPIOID

From the Ears of William Hanwell

BACKDOOR - This morning, SoHo awoken to another three OD’s from the newest drug wave hitting the city, colloquially dubbed “Liedown”, for its infamous effects on users, crumpling them into a body-numbing calm — a potentially fatal one. Despite best efforts by local police to take it off the streets, supply is rising endlessly, and so is demand.
Liedown first made its debut just three months ago, being sold as a brand new extremely effective pain reliever by local dealers. Unfortunately, it became extremely clear what the risks were: even slight misuse led to prolonged unconsciousness, and potentially, brain death, a nap which you wouldn’t wake up from, perplexing even the brightest minds in the arts of medical science and magicks.

Official investigations started month, but the long overdue search has yielded no results, and only yielding deep controversy, following the July 27th raid on multiple anartist groups in Old New Broadway, leaving the public outraged on what they view as a “discriminatory” attack based on pure stereotype.

Suspected group Marshall, Carter & Dark has also shown fruitless results, leading to doubt over whether this inquisition can be trusted with any responsibility. However, with the newfound collaboration from the Unusual Incidents Unit (UIU), Police Chief Robert Hannagan believes a breakthrough will occur soon.

“It is without doubt that I, and the entirety of the BackDoor police force, believe that with our new resources, whoever’s peddling this ‘Liedown’ will be found and caught shortly. And when they do, I can assure that they will be punished to the full extent of the law’s capabilities.” Hannagan claimed in a recent interview.

Of course, suspicions run amok amongst the populous themselves. Many question whether occult activities are to blame for this mess, or perhaps one of the many corporations taking up shop, to the chagrin of the locals. So far, no responses have been given from…

.

.

.

Excerpt from UIU File: 2026-089, Interrogation Record. For approved staff ONLY. Authorized stories to be given to press next week, August 25th. Prepare for media response.


McKinsley: Say it again for the record, please. Name and occupation.

Farnesi: Doctor Fausto Farnesi. CEO of Febris Pharmaceuticals.

McKinsley: So, Doctor, you are fully claiming to have produced “Liedown” and sent your supply of it to dealers citywide?

Farnesi: Yes. My company produced a new, very effective painkiller drug—“Anedonia”. We sold this through certain authorized channels, with very specific instructions for using them.

McKinsley: Interesting for you to say such a brazen confession immediately. Additionally so for you to approach us with this.

Farnesi: I swore to be utterly truthful for this interview, and I have been. Our company has always had honesty as one of its core tenants. Why else would I request to speak?

McKinsley: Yet you seem okay dealing illegal substances towards addicts in this town.

Farnesi: No, I do not. And we, as a company, do not.

McKinsley: Is there something in my statement you deem contradictory?

Farnesi: Regulations regarding distribution of medical products state that legal requirements for approved selling of a product requires nothing more than valid medical testing and proper disclosure in taking it.

McKinsley: How does that factor in?

Farnesi: Our product has been properly tested and found to be beneficial — as long as you follow the recommended frequency of consumption. Which is once per week. Which we have strictly told our proxies to say.

McKinsley: Your dealers.

Farnesi: Proxies. Legal proxies which are able to sell our product, under our guidance. If they are selling anything actually illegal, that’s beyond our knowledge.

McKinsley: But how do you explain the overdoses? Almost fifty overdoses that we know of. Probably double that we don’t.

Farnesi: Warnings were given, waivers signed, which we would gladly supply, and which our proxies would back. Legally, it is ‘user error’.

McKinsley: Regardless of legality, there’s no possibility that a substance that dangerous will be allowed for production.

Farnesi: Well, this is what was forced upon us. And I would not recommend stopping production now.

McKinsley: Why not?

Farnesi: Well, all our company is doing is offering people a clean, relatively cheap way of ending their horrible, constant, pain. Their panacea of suffering, if you would.

McKinsley: So? It’s still seriously addictive. We have a duty to this nexus, and-

Farnesi: And surveys claim up to 38% of BackDoor SoHo have some form of diagnosed chronic injury, that’s about thousand people? Ten thousand people left without our Anedonia. Ten thousand angry, suffering civilians, who know who to blame for it.

McKinsley: That’s absurd. There are alternatives to your drug already in market.

Farnesi: Not in price. And certainly not in effectiveness. And the secrets to our products are, how do you say it, exclusive.

McKinsley: So what do you want from us?

Farnesi: Nothing at all, Detective, quite literally. Let us sell to official stores, with your endorsement and regulations. And that you stop the fearmongering stories about our product.

McKinsley: Then you’ll stop peddling your product it to street vendors? Just like that?

Farnesi: Just like that.

McKinsley: …what are you planning, Doctor?

Farnesi: Well… you’ll see.

.

.

.

Final draft, requires approval from Board. Not to be published.

FEBRIS PHARMACEUTICALS

Logo%20Febris%20Nuovo

"Nostrum malum, nostra salus"


Anedonia®

1. What is Anedonia® and what is it used for?

Anedonia® is a revolutionary newly developed painkiller, offering relief from chronic pains for up to a week per use, as well as long lasting periods of calm for those dealing with prolonged episodes of stress.

Anedonia® comes in the form of simple tablets, allowing a painless and stress-free intake experience, available in all Febris-sanctioned pharmacies and stores.

2. Contraindications/Interactions with other drugs:

Do not take Anedonia® alongside other medications that offer similar effects (ex. Vicodin®, Percocet®, etc.), as this could lead to severe health defects. Do not take Anedonia® if you are undergoing chemotherapy or physiologically similar treatments. Consult your nearest Febris professional for further concerns.

3. Composition:

Synthetic codeine, synthetic papaverine, Anedonic hydrochloride (FP - Patent #08-C), Bene Nocte-strengthened Lidocaine (FP - Patent #08-D)

4. Description of effects:

Causes elongated relief of joint and muscle pain, especially ones caused by chronic illnesses for up to seven days after consumption. Additionally causes more relaxed moods for the same time period, even in normally stressful situations.

5. How to take Anedonia®:

Safe consumption of Anedonia® must be done once per week, and not sooner. Spacing it out further is recommended if the effects do not end after the usual seven-day period. Consult your nearest Febris-endorsed pharmacy for special conditions and how to schedule your Anedonia®.

6. Overdose:

Mild overuse of Anedonia® may cause sudden headaches or migraines, as well as mild muscle paralysis. Major overdose can lead to seizures, total body paralysis, or in very rare cases, death. It is strongly recommended have someone nearby when consuming your regular Anedonia® tablet to ensure safety.

7. Side Effects:

Prolonged intake of Anedonia® (6+ months) can lead to longer periods of REM sleep at night, as well as a possible chance for mild insomnia. It is recommended to stop taking Anedonia® if side effects become debilitating on day-to-day life.

8. How to store Anedonia®:

Keep Anedonia® in plastic containers. Anedonia® can be stored in cool or room temperature environments. Do not keep Anedonia® exposed to intense heat.

Febris Pharmaceuticals S.p.A. - Florence, IT

ATTACHED NOTE TO AUTHORIZED EMPLOYEES — DELETE LATER

Begin shipping of FP-938 “Anedonia” next week to marked locations, make sure all transports are viable. Regarding media exposure: follow normal procedure in worst case scenario. Flagged keywords: “deaths”, “overdose”, “Liedown”, “coma”, “brain death”, “screaming”.

Await further instructions.

- F.F.

interrogation · REC-1469122939End of document

Referenced by

2 records